AbCheck

Plzen, Czechia Founded: 2009 • Age: 17 yrs Acquired By Ampersand
Developer of human therapeutic antibodies
Request Access

About AbCheck

AbCheck is a company based in Plzen (Czechia) founded in 2009 was acquired by Ampersand in January 2024.. AbCheck operates in a competitive market with competitors including Adimab, Aphios, CDI Labs, QuaDRAD and OmniAb, among others.

  • Headquarter Plzen, Czechia
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Abcheck S.R.O.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Ampersand

    (Jan 03, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of AbCheck
Headcount 10-50
Employee Profiles 2
Employee Profiles
People
Claudia Wurzenberger
VP Project Management

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of AbCheck

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AbCheck

AbCheck has secured backing from 1 investor. Prominent investors backing the company include Ampersand. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Programmable medicines are developed to target and treat multiple diseases.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AbCheck

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AbCheck

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Abcheck Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AbCheck

AbCheck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adimab, Aphios, CDI Labs, QuaDRAD and OmniAb, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Antibodies are discovered and optimized for autoimmune and infectious diseases.
domain founded_year HQ Location
Therapeutics for cancer and infectious diseases are developed.
domain founded_year HQ Location
Autoantibody detection and profiling products and services are provided.
domain founded_year HQ Location
Antibody drug discovery platform
domain founded_year HQ Location
Transgenic animal platforms are developed for human therapeutic antibody production.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Abcheck

Frequently Asked Questions about AbCheck

When was AbCheck founded?

AbCheck was founded in 2009.

Where is AbCheck located?

AbCheck is headquartered in Plzen, Czechia. It is registered at Plzen, Plzen Region, Czechia.

What does AbCheck do?

AbCheck is a spin-out of Affimeds technology platform (part of Affimed). They are involved in the development of human therapeutic antibodies for treating cancer. The company offers proprietary platforms including proprietary libraries, rabbit mass humanization, AbSieve (antibody screeningselection tool), and AbAccel (antibody optimization in a single process).

Who are the top competitors of AbCheck?

AbCheck's top competitors include Adimab, Aphios and OmniAb.

Who are AbCheck's investors?

AbCheck has 1 investor. Key investors include Ampersand.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available